Takeda to Cut Costs by 100 Billion Yen, Reduce Workforce by Below 5%

Takeda Pharmaceutical will cut 100 billion yen in its operating costs by FY2017 through cost-cutting measures such as the optimization of sales and marketing effectiveness, central purchasing, and the integration of its research and development functions, the company said on...read more